Abstract
Background: Ductal carcinoma in situ with microinvasion (DCISM) is a rare subtype of DCIS, with a foci of tumour cells penetrating through the basement membrane (no more than 1mm). Since 2015 to 2019, there have only been 3 (5.7%) cases in the breast unit at Hillingdon Hospitals NHS Foundation Trust (THH), a district general hospital in London. A conundrum for surgeons is that definitive diagnosis is only made upon histological examination of the final surgical specimen.. In addition to this, in the UK, there are no specific guidelines on the role of axillary staging in the management of DCISM cases. As a result, there is ongoing controversy surrounding the most appropriate management of DCISM, in particular the need of axillary staging.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
